17-acetamido-4-azasteroid derivatives as androgen receptor modulators

Details for Australian Patent Application No. 2004259664 (hide)

Owner Merck & Co., Inc.

Inventors Meissner, Robert S.; Mitchell, Helen J.; Dankulich, William P.

Agent Spruson & Ferguson

Pub. Number AU-B-2004259664

PCT Pub. Number WO2005/009949

Priority 60/483,680 30.06.03 US

Filing date 25 June 2004

Wipo publication date 3 February 2005

Acceptance publication date 28 May 2009

International Classifications

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61K 31/473 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines

A61K 31/5377 (2006.01)

A61K 31/585 (2006.01)

A61P 5/26 (2006.01) Drugs for disorders of the endocrine system

A61P 5/28 (2006.01) Drugs for disorders of the endocrine system

C07D 221/18 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07J 73/00 (2006.01) Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms

Event Publications

19 January 2006 PCT application entered the National Phase

  PCT publication WO2005/009949 Priority application(s): WO2005/009949

28 May 2009 Application Accepted

  Published as AU-B-2004259664

24 September 2009 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004259669-CCI-779 Isomer C

2004259662-5-membered heterocycle-based p38 kinase inhibitors